Back to Archived News
Idaho Technology Exclusive Licensee of Patent Covering Majority of Real-Time PCR Instruments on Market
Thursday, April 01, 2010
Salt Lake City, UT -- The U.S. Patent and Trademark Office has granted U.S. Patent No. 7,670,832, reaching claims that apply to most of the real-time PCR instruments on the market. Idaho Technology, Inc. is the exclusive licensee of this patent. This most recent patent to issue in the company’s growing portfolio relates to methods of performing nucleic acid analysis in the presence of a fluorescent dye.
The patent broadly covers devices for performing Polymerase Chain Reaction (PCR) followed by melt curve analysis using fluorescent dyes, including melt curve analysis using dsDNA binding dyes such as SYBR Green or probes labeled with a fluorescent dye.
Idaho Technology has licensed or is in the process of licensing this patent to a number of major PCR instrument manufacturers.
About Idaho Technology
Idaho Technology, Inc. is a privately held biotechnology company based in Salt Lake City, Utah. Founded in 1990, Idaho Technology licensed the rapid PCR technology from the University of Utah. Through funds from the United States Department of Health and Human Services and the Department of Defense, the company has created many commercial instruments and reagents for use in research and applied fields. Several of these products, including the LightCycler® Instrument, have been sublicensed to Roche Diagnostics. Researchers, medical technicians, law enforcement officers, and soldiers in the field use the company's devices to detect or study disease-causing organisms. For further information, please visit www.idahotech.com.
Back to Archived News
